NEWS & ANNOUNCEMENTS

Chairman of VIVA Foundation for Children with Cancer (VIVA), Mrs. Jennifer Yeo, will be featured on the upcoming <我董你> programme on Channel 8 TV

Chairman of VIVA Foundation for Children with Cancer (VIVA), Mrs. Jennifer Yeo, will be featured on the upcoming <我董你> programme on Channel 8 TV this Sunday 19th Jan 2025, at 9 PM! Mrs Yeo will be sharing more about VIVA. Stay tuned!

Congratulations to Prof Allen Yeoh and his team on their groundbreaking cancer treatment breakthrough!

Congratulations to Prof Allen Yeoh and his team on their groundbreaking cancer treatment breakthrough! Your dedication to fighting childhood cancer is truly inspiring. We're honoured to support innovative research such as this.

See all

VIVA Gut Microbiome and Cancer Education Webinar Series:

Gut Microbiome and Cancer Development and Diagnosis

10 Sept 2022 (Saturday) | 08:30 - 09:30 (UTC+8 | SGT) | Check your Time Zone

Programme Synopsis

The microbiome is a complex ecosystem of billions of microbes that resides in the human gut. This microbiome has a profound impact on human health, and disruptions to its composition have been linked to a variety of diseases. Recently, the microbiome has also been implicated in the development and progression of some cancers. There are several mechanisms by which gut microbes can contribute to cancer development. For example, certain bacteria can produce compounds that damage DNA, promote inflammation, or alter the way the body processes metabolites. These changes can increase the risk of tumour formation. In addition, the microbiome can influence the body's immune response to cancerous cells, affecting both tumour growth and the effectiveness of treatments. The microbiome may also play a role in cancer diagnosis. For instance, certain patterns of microbial activity have been associated with specific types of digestive cancer. For example, microbiome-based diagnostic tests may be able to identify cancerous tumours more accurately at an early stage when they are most treatable. Further research is needed to fully understand the role of the microbiome in digestive cancer development and diagnosis. This emerging area of study holds great promise for improving our ability to prevent and treat this disease.

Watch it Again!

SPEAKER

A/Prof Sunny Wong

Associate Professor of Nutrition, Digestion and Metabolism and Assistant Dean, Academic Medicine, Lee Kong Chian School of Medicine
Associate Professor, Lee Kong Chian School of Medicine
Nanyang Technological University
Singapore

Dr Sunny Wong is a clinician-scientist and an Associate Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. He received his MBChB with Honors at the Chinese University of Hong Kong, and his DPhil in University of Oxford on human genetics and infectious diseases. He completed his clinical training in gastroenterology and endoscopy in the Prince of Wales Hospital Hong Kong. His main research interest is on gut microbiome, investigating the host-microbe interaction in digestive and metabolic diseases, and exploring this for discovery of novel biomarkers and therapeutics. He has won several awards, including the Asia Pacific Digestive Week Emerging Leaders Lectureship (2021), the Sir David Todd Lectureship (2020), the Lo Ying Shek Chi Wai Foundation Meritorious Research Award (2020), and the Croucher Foundation Award (2014). He has published over 160 peer-reviewed articles including papers in Nature Genetics, Nature Communications, Gastroenterology and Gut. He is currently an Associate Editor for the Journal of Gastroenterology and Hepatology.

VIVA Gut Microbiome and Cancer Education Webinar Series:

Gut Microbiome and Cancer Prevention

3 Dec 2022 (Saturday) | 08:30 - 09:30 (UTC+8 | SGT) | Check your Time Zone

WATCH IT AGAIN!

SPEAKER

Professor Joseph J Y Sung

Distinguished University Professor
Senior Vice President (Health & Life Sciences)
Dean, Lee Kong Chian School of Medicine
Nanyang Technological University, Singapore

Professor Sung received his medical degree (MBBS) from The University of Hong Kong, and conferred PhD in biomedical sciences by the University of Calgary and MD by The Chinese University of Hong Kong (CUHK). He holds fellowships from the Royal Colleges of Physicians of Edinburgh, Glasgow, London, and Australia, the American College of Gastroenterology, the American Gastroenterological Association, the Hong Kong College of Physicians, the Hong Kong Academy of Medicine and Academy of Sciences of Hong Kong (ASHK). He is an Academician of the Chinese Academy of Engineering of the People's Republic of China and Academician of the International Eurasian Academy of Sciences. He served as the Vice-Chancellor and President of the Chinese University of Hong Kong (2010 – 2017) and the Chair of Worldwide Universities Network (2016 - 2017).

Professor Sung is currently Distinguished University Professor, Senior Vice President (Health & Life Sciences) and Dean, Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. He is also Emeritus Professor of Medicine at CUHK.

He has published over 1000 full scientific articles in leading medical and scientific journals. He was listed as “Highly Cited Researchers”, released by the Clarivate Analytics, for the years 2018 to 2021. He has edited and authored around 30 books, as well as many chapters in major textbooks including the Oxford Textbook of Medicine (5th Ed.), Sleisenger & Fordtran's Gastrointestinal and Liver Disease (7th&8th Ed) and Yamada’s Textbook of Gastroenterology (4th Ed).